Optilume Urethral Drug Coated Balloon
Payments companies reported to CMS as associated with Optilume Urethral Drug Coated Balloon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optilume Urethral Drug Coated Balloon, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optilume Urethral Drug Coated Balloon
These are the largest totals companies reported as associated with Optilume Urethral Drug Coated Balloon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sean Elliott | Minneapolis, MN | Urology | $85,003.63 |
| Allen Morey | Dallas, TX | Urology | $33,311.53 |
| Michael Borofsky | Indianapolis, IN | Urology | $20,500.00 |
| Jeffrey Dann | Palm Coast, FL | Urology | $10,253.12 |
| Lucas Wiegand | Orlando, FL | Urology | $5,323.90 |
| Michael Ehlert | Woodbury, MN | Urogynecology and Reconstructive Pelvic Surgery (Urology) | $4,288.19 |
| Jaime Landman | Orange, CA | Urology | $3,600.00 |
| Michael Kennelly | Charlotte, NC | Urology | $1,925.00 |
| Jack Walter | Tacoma, WA | Urology | $1,249.85 |
| Lee Zhao | New York, NY | Urology | $1,012.50 |
Prescribed Optilume Urethral Drug Coated Balloon?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.